SIGNIFICANCE OF DIAGNOSTICS OF THE EPSTEIN-BARR VIRUS BY THE ELISA METHOD

Authors

  • Yodgorova N.T Tashkent Medical Academy
  • Abdullayev U.M Tashkent Medical Academy
  • Eshbekova L.SH Tashkent Medical Academy

Keywords:

Epstein-Barr virus, Immunoenzyme analysis, mononucleosis, oncological diseases

Abstract

Investigation of anti-EBV IgM va anti-EBV IgG against the Epstein-Barr virus by ELISA and antigen analysis. Material and methods: Materials of the InterMed private clinic located in the Yunusabad district of Tashkent in 2022 were used. For the study, 5 ml of blood from the wrist vein was taken from patients and examined by ELISA (BektoVEB-VCA-IgG-IGM, D2176, D-2184, Vector-Best JSC, Novosibirsk). The results obtained were subjected to statistical processing

References

Gurtsevich . V.E. Epstein-Barr virus and classical Hodgkin's lymphoma. Clinical oncohematology. 2016;9(2 ). pp. 101-114

Djumamurodov , S. T., Yodgorova N. T. (2018). Evaluation of VICh resistance by the molecular-genetic method "sukhaya kaplya krovi". Redkollegia, 124

Nuruzova Z.A., Faizullaeva Z. , Mamatmusaeva F.Sh. , Seyfullaeva B.S. Sovremennaya laboratornaya diagnostika, chebno-methodicheskoe posobie, Tashkent 2021, 40 str.

Smirnova K.V., Diduk S.V., Senyuta N.B., Gurtsevich V.E. Molecular and biological properties of the LMP1 gene of the Epstein- Barr virus : structure, function and polymorphism. Voprosy virology . 2015;60(3):5–13.

Yodgorova NT, Abdiyeva MB , Eshbekova L.SH. Immunoenzyme analysis method Epstein -Barr virus diagnosis and his prospects ///

Rickinson AB, Long HM, Palendira U, et al. Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratory Trends Immunol . 2014;35(4):159–69. doi : 10.1016/j.it.2014.01.003.

Ogembo JG, Kannan L, Ghiran I, et al. Human complement receptor type 1/CD35 is an Epstein-Barr Virus receptor. Cell Rep. 2013 ;3 (2):371– 85.doi:10.1016/j.celrep.2013.01.023.

Kempkes B, Robertson ES. Epstein-Barr virus latency: current and future perspectives. Curr Opin Virol . 2015 ;14:138–44 . doi : 10.1016/j.coviro.2015.09.007.

Guo L, Tang M, Yang L, et al. Epstein-Barr virus oncoprotein LMP1 mediates surviving upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinoma. Int J Mol Med. 2012;29(4):574–80. doi : 10.3892 ijmm.2012.889

Xiao L, Hu ZY, Dong X, et al. Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy . Oncogene. 2014;33(37):4568–78. doi : 10.1038/onc.2014.32.

Engels N, Young G, Emmerich CH, et al. Epstein-Barr virus LMP2A signaling in statu nascendi mimics a B cell antigen receptor-like activation signal. Cell Commun Signal. 2012;10(1):9. doi : 10.1186/1478-811 X -10-9.

Mamatova , R.N., Mirkasimova , H.Kh., & Abdullaev, U.M. HANTAVIRUS NAYA INFEKTSIYA I LIKHORADKA ZAPADNOGO NILA SLUChAY IZ PRACTICE.

Downloads

Published

2023-03-10

How to Cite

Yodgorova N.T, Abdullayev U.M, & Eshbekova L.SH. (2023). SIGNIFICANCE OF DIAGNOSTICS OF THE EPSTEIN-BARR VIRUS BY THE ELISA METHOD. World Bulletin of Public Health, 20, 34-37. Retrieved from https://scholarexpress.net/index.php/wbph/article/view/2315

Issue

Section

Articles

Most read articles by the same author(s)